AbbVie (BSP:ABBV34) Purchase Of Investment : R$-383 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AbbVie Purchase Of Investment?

AbbVie's purchase of investment for the three months ended in Dec. 2023 was R$-167 Mil. It means AbbVie spent R$167 Mil on purchasing investments. AbbVie's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was R$-383 Mil.

Compared with last quarter (R$-40 Mil in Sep. 2023 ), AbbVie spent more money on purchasing investments in Dec. 2023 (R$-167 Mil).

AbbVie Purchase Of Investment Historical Data

The historical data trend for AbbVie's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Purchase Of Investment Chart

AbbVie Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

Get a 7-Day Free Trial

-2,392.92

-313.83

-672.93

-7,542.89

-377.29

AbbVie Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Investment	Get a 7-Day Free Trial															-98.96	-77.66	-39.51	-166.59	-

AbbVie Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-383 Mil.

AbbVie Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of AbbVie's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie (BSP:ABBV34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV:Austria

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

http://www.abbvieinvestor.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (BSP:ABBV34) Headlines

No Headlines